Research Fellowships are intended to support the development of the next generation of physician scientists and the advancement of active research projects in the field of pediatric dermatology.
Childhood skin diseases are associated with a severe burden on patients, families, and healthcare providers. Despite this burden, effective treatments remain sparse, and the pace of research remains slow. To help overcome these challenges while developing the next generation of leaders in the field, the Pediatric Dermatology Research Alliance (PeDRA) is offering the Emerging Investigator Research Grants (EIRG) program to support short-term (12-week maximum) mentored research experiences for medical students and pediatric residents to conduct projects relevant to pediatric dermatology.
Intended to provide financial support for early-stage studies that are unlikely to be funded elsewhere, and to provide a mentorship opportunity for both grant preparation and project execution. Ultimately, PeDRA Research Grants are expected to generate data, establish research infrastructure, and foster collaborations that form the basis for larger scale studies with a high impact on patient lives.
The Weston CDA is driven by PeDRA’s and SPD’s commitment to support both research and researchers in the field of pediatric dermatology. It is intended to provide protected research time, resources, and expert mentorship for an early career clinician scientist. Ultimately, the Weston CDA is expected to help position the recipient for a long-term career in the field with the potential to obtain funding from the Dermatology Foundation, NIH, or other agencies in future.
The Career Bridge Research Grant is driven by PeDRA’s commitment to support both research and researchers in the field of pediatric dermatology. It is intended to provide protected research time and resources for a mid-career clinician scientist conducting high-impact research in the field. Ultimately, the Career Bridge Research Grant is expected to propagate the career of the recipient through the challenging mid-career phase and give them the potential to obtain larger-scale, longer-term funding from the NIH or other agencies.